Artal Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-75,000	Closed	-$1.45M	–	133
2022 Q2	$1.45M	Hold	75,000	–	–	0.08%	108
2022 Q1	$964K	Buy	+75,000	New	+$964K	0.04%	123